No clinical data on the treatment of silicosis patients with G-CSF have been reported, but its pathway inhibition, as with PDGF, VEGF and FGF signaling inhibition, could attenuate lung fibrosis [68]. This evidence concerns the gene VEGFA and pulmonary fibrosis.